We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
58 hedge funds and large institutions have $99.5M invested in Corvus Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
8% more capital invested
Capital invested by funds: $92.2M → $99.5M (+$7.37M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1.39% less ownership
Funds ownership: 85.83% → 84.44% (-1.4%)
5% less funds holding
Funds holding: 61 → 58 (-3)
17% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 23
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
58
Holders Change
-3
Holders Change %
-4.92%
% of All Funds
1.26%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
3
Increased
19
Reduced
23
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$957K |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$924K |
| 3 |
Renaissance Technologies
New York
|
+$504K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$359K |
| 5 |
Morgan Stanley
New York
|
+$97.6K |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$1.08M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$826K |
| 4 |
CI
Cowen Inc
New York
|
-$317K |
| 5 |
JP Morgan Chase
New York
|
-$262K |
